Literature DB >> 15957192

Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice.

Mugimane G Manjanatha1, Anane Aidoo, Sharon D Shelton, Michelle E Bishop, Lea P McDaniel, Lascelles E Lyn-Cook, Daniel R Doerge.   

Abstract

The recent discovery of acrylamide (AA), a probable human carcinogen, in a variety of fried and baked starchy foods has drawn attention to its genotoxicity and carcinogenicity. Evidence suggests that glycidamide (GA), the epoxide metabolite of AA, is responsible for the genotoxic effects of AA. To investigate the in vivo genotoxicity of AA, groups of male and female Big Blue (BB) mice were administered 0, 100, or 500 mg/l of AA or equimolar doses of GA, in drinking water, for 3-4 weeks. Micronucleated reticulocytes (MN-RETs) were assessed in peripheral blood within 24 hr of the last treatment, and lymphocyte Hprt and liver cII mutagenesis assays were conducted 21 days following the last treatment. Further, the types of cII mutations induced by AA and GA in the liver were determined by sequence analysis. The frequency of MN-RETs was increased 1.7-3.3-fold in males treated with the high doses of AA and GA (P < or = 0.05; control frequency = 0.28%). Both doses of AA and GA produced increased lymphocyte Hprt mutant frequencies (MFs), with the high doses producing responses 16-25-fold higher than that of the respective control (P < or = 0.01; control MFs = 1.5 +/- 0.3 x 10(-6) and 2.2 +/- 0.5 x 10(-6) in females and males, respectively). Also, the high doses of AA and GA produced significant 2-2.5-fold increases in liver cII MFs (P < or = 0.05; control MFs = 26.5 +/- 3.1 x 10(-6) and 28.4 +/- 4.5 x 10(-6)). Molecular analysis of the mutants indicated that AA and GA produced similar mutation spectra and that these spectra were significantly different from that of control mutants (P < or = 0.001). The predominant types of mutations in the liver cII gene from AA- and GA-treated mice were G:C-->T:A transversions and -1/+1 frameshifts in a homopolymeric run of Gs. The results indicate that both AA and GA are genotoxic in mice. The MFs and types of mutations induced by AA and GA in the liver are consistent with AA exerting its genotoxicity in BB mice via metabolism to GA. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15957192     DOI: 10.1002/em.20157

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  16 in total

1.  Carcinogenicity of glycidamide in B6C3F1 mice and F344/N rats from a two-year drinking water exposure.

Authors:  Frederick A Beland; Greg R Olson; Maria C B Mendoza; M Matilde Marques; Daniel R Doerge
Journal:  Food Chem Toxicol       Date:  2015-09-30       Impact factor: 6.023

2.  Epigenetic regulation of genetic integrity is reprogrammed during cloning.

Authors:  Patricia Murphey; Yukiko Yamazaki; C Alex McMahan; Christi A Walter; Ryuzo Yanagimachi; John R McCarrey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

3.  Gene expression changes associated with xenobiotic metabolism pathways in mice exposed to acrylamide.

Authors:  Nan Mei; Lei Guo; Jo Tseng; Stacey L Dial; Wayne Liao; Mugimane G Manjanatha
Journal:  Environ Mol Mutagen       Date:  2008-12       Impact factor: 3.216

4.  Mutagenicity of acrylamide and glycidamide in the testes of big blue mice.

Authors:  Rui-Sheng Wang; Lea P McDaniel; Mugimane G Manjanatha; Sharon D Shelton; Daniel R Doerge; Nan Mei
Journal:  Toxicol Sci       Date:  2010-06-25       Impact factor: 4.849

5.  Tumorigenicity of acrylamide and its metabolite glycidamide in the neonatal mouse bioassay.

Authors:  Linda S Von Tungeln; Daniel R Doerge; Gonçalo Gamboa da Costa; M Matilde Marques; William M Witt; Igor Koturbash; Igor P Pogribny; Frederick A Beland
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

6.  Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study.

Authors:  Kathryn M Wilson; Katarina Bälter; Hans-Olov Adami; Henrik Grönberg; Anna C Vikström; Birgit Paulsson; Margareta Törnqvist; Lorelei A Mucci
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

7.  Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide.

Authors:  Kathryn M Wilson; Hubert W Vesper; Paula Tocco; Laura Sampson; Johan Rosén; Karl-Erik Hellenäs; Margareta Törnqvist; Walter C Willett
Journal:  Cancer Causes Control       Date:  2008-10-15       Impact factor: 2.506

8.  Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004.

Authors:  Hubert W Vesper; Samuel P Caudill; John D Osterloh; Tunde Meyers; Deanna Scott; Gary L Myers
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

9.  Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.

Authors:  Nan Mei; Jiaxiang Hu; Mona I Churchwell; Lei Guo; Martha M Moore; Daniel R Doerge; Tao Chen
Journal:  Food Chem Toxicol       Date:  2007-09-22       Impact factor: 6.023

10.  Effect of dose volume on the toxicokinetics of acrylamide and its metabolites and 2-deoxy-D-glucose.

Authors:  Burhan I Ghanayem; Re Bai; Leo T Burka
Journal:  Drug Metab Dispos       Date:  2008-11-20       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.